A Randomized Clinical Trial to Study the Effects of Infliximab on Clinical Efficacy and Hand and Wrist Magnetic Resonance Imaging (MRI) in Patients With Active Rheumatoid Arthritis (RA)(Protocol No. P08136)
Latest Information Update: 11 May 2022
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
Most Recent Events
- 11 Apr 2012 Actual patient number 61 added as reported by ClinicalTrials.gov.
- 11 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.